NACL Industries Ltd

NACL Industries Ltd

₹ 62.4 1.38%
18 Apr - close price
About

NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions. [1] [2]

Key Points

Products[1]
Key technicals:
Insecticides: Cairo, Fenny, Nagarjuna 4G, PestLock, etc.
Herbicides: Font, Slogan, Nagarjuna Combi plus, etc.
Fungicides: Combi plus, Kazan, Result, Subtle Plant Growth Regulators :Atonik, Gallant EG, Gallant Gold
Company has 63 branded products.[2]

  • Market Cap 1,247 Cr.
  • Current Price 62.4
  • High / Low 105 / 55.4
  • Stock P/E
  • Book Value 26.9
  • Dividend Yield 1.12 %
  • ROCE 15.2 %
  • ROE 18.0 %
  • Face Value 1.00

Pros

Cons

  • Company has low interest coverage ratio.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
265 330 325 443 400 471 475 565 480 599 376 580 365
239 302 296 402 370 431 442 511 443 531 405 550 361
Operating Profit 26 29 28 41 29 40 33 54 38 67 -29 31 4
OPM % 10% 9% 9% 9% 7% 8% 7% 10% 8% 11% -8% 5% 1%
3 6 3 5 4 2 2 3 3 4 3 1 2
Interest 8 6 6 6 7 7 8 10 12 17 18 20 19
Depreciation 6 6 6 6 6 6 7 7 6 9 7 7 7
Profit before tax 14 23 19 33 20 27 20 40 22 46 -51 6 -20
Tax % 36% 23% 25% 27% 29% 25% 26% 25% 25% 27% 25% 28% 22%
9 17 14 24 14 20 15 30 17 34 -38 4 -16
EPS in Rs 0.47 0.89 0.72 1.23 0.73 1.03 0.75 1.51 0.83 1.69 -1.91 0.21 -0.80
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
643 601 636 746 692 735 847 865 1,015 1,191 1,633 2,116 1,920
572 583 625 701 636 679 798 852 946 1,078 1,495 1,922 1,847
Operating Profit 71 18 11 44 56 56 49 14 69 113 138 193 73
OPM % 11% 3% 2% 6% 8% 8% 6% 2% 7% 10% 8% 9% 4%
4 18 16 26 18 41 20 27 8 15 13 10 10
Interest 33 31 28 35 37 38 33 34 29 28 27 47 74
Depreciation 27 25 22 25 27 28 20 20 24 25 25 28 29
Profit before tax 14 -20 -23 10 11 31 15 -13 24 75 100 128 -19
Tax % 49% 36% 9% 27% 18% -4% 25% 48% 30% 32% 26% 26%
7 -13 -21 8 10 33 12 -7 17 51 73 95 -16
EPS in Rs 0.40 -0.70 -1.32 0.54 0.62 2.09 0.74 -0.42 0.87 2.60 3.70 4.77 -0.81
Dividend Payout % 31% 0% 0% 19% 16% 6% 17% 0% 12% 15% 15% 15%
Compounded Sales Growth
10 Years: 13%
5 Years: 20%
3 Years: 28%
TTM: -4%
Compounded Profit Growth
10 Years: 25%
5 Years: 51%
3 Years: 78%
TTM: -120%
Stock Price CAGR
10 Years: 26%
5 Years: 16%
3 Years: 18%
1 Year: -27%
Return on Equity
10 Years: 9%
5 Years: 12%
3 Years: 16%
Last Year: 18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 15 15 16 16 16 16 16 17 19 20 20 20 20
Reserves 192 180 159 162 170 213 223 247 338 397 469 554 516
220 177 219 228 232 213 237 210 268 202 531 724 775
204 228 227 260 193 209 237 268 330 357 496 616 637
Total Liabilities 631 600 621 665 611 651 713 742 955 976 1,516 1,914 1,948
192 172 182 176 167 163 158 141 191 220 238 402 447
CWIP 16 11 18 12 6 7 5 21 42 36 116 71 32
Investments 4 4 9 12 13 9 9 14 15 16 13 14 15
419 413 411 466 426 473 541 566 707 704 1,148 1,427 1,454
Total Assets 631 600 621 665 611 651 713 742 955 976 1,516 1,914 1,948

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
36 76 31 40 46 58 24 36 103 83 -124 -20
-24 -5 -47 -18 -12 -6 -14 -27 -97 14 -163 -143
-10 -74 11 -27 -33 -58 -11 -9 70 -113 290 134
Net Cash Flow 2 -3 -5 -4 1 -5 -1 0 77 -16 2 -28

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 111 100 92 108 99 110 124 113 129 103 118 133
Inventory Days 148 154 140 138 153 189 141 134 84 100 124 112
Days Payable 123 113 97 121 89 127 127 125 137 120 112 110
Cash Conversion Cycle 135 141 135 125 163 172 137 122 76 83 129 135
Working Capital Days 108 97 93 90 119 126 124 125 90 89 123 128
ROCE % 3% 2% 11% 12% 10% 11% 4% 10% 17% 15% 15%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
64.16% 64.16% 64.16% 64.00% 63.97% 63.97% 63.97% 63.83% 63.83% 63.83% 63.80% 63.72%
1.96% 1.98% 1.85% 1.87% 1.85% 1.87% 1.50% 1.20% 1.16% 1.03% 0.50% 0.28%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.23% 0.47% 0.81% 0.96% 0.96% 0.96%
33.88% 33.86% 33.99% 34.13% 34.18% 34.14% 34.30% 34.49% 34.20% 34.18% 34.75% 35.04%
No. of Shareholders 18,55417,84421,64522,85524,07423,91123,65522,95222,44824,81026,94230,814

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls